Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B
about
Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation.Meta-analysis of the short-term effects of lamivudine treatment for severe chronic hepatitis B.Combined adenovirus-mediated artificial microRNAs targeting mfgl2, mFas, and mTNFR1 protect against fulminant hepatic failure in mice.Immune mediated liver failure.Physiological functions and clinical implications of fibrinogen-like 2: A review.Early warning and clinical outcome prediction of acute-on-chronic hepatitis B liver failureMouse Hepatitis Virus Infection Induces a Toll-Like Receptor 2-Dependent Activation of Inflammatory Functions in Liver Sinusoidal Endothelial Cells during Acute Hepatitis.Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma.Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).Acute liver failure: mechanisms of immune-mediated liver injury.Definition of ACLF and inclusion criteria for extra-hepatic organ failure.Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis.Nucleoside analogs prevent disease progression in HBV-related acute-on-chronic liver failure: validation of the TPPM model.The significance of microthrombosis and fgl2 in no-reflow phenomenon of rats with acute myocardial ischemia/reperfusion.Entecavir treatment prevents disease progression in hepatitis B virus-related acute-on-chronic liver failure: establishment of a novel logistical regression model.Gene transfer of c-met confers protection against D-galactosamine/lipopolysaccharide-induced acute liver failure.Construction of plasmids expressing Sars-CoV encoding proteins and their effects on transcription of hfgl2 prothrombinase.
P2860
Q34552034-E35A5FBE-71D7-4B9D-83FC-CE7E5D16FB39Q34694495-61B06C86-157F-4A1D-AC9A-10AF4A4ED675Q35058696-C6DAE316-0894-41BF-9123-56DA74E04E50Q35729249-36623402-3BAA-4B69-A785-A58645B596DBQ35828805-B3A3463E-49FC-4AA5-931D-D2F5017A6BDCQ36269654-CCB94D01-DE86-475B-918E-DDB5AC555030Q37300472-B5B65AA2-654B-4B37-8D82-739759687F51Q37383169-A11B8B2B-3C97-4C74-9B04-3492041465AFQ37577568-9354A660-F4C4-4B60-8B4B-1C6E0D3BD9B4Q37759247-517F88D4-0241-4128-90C9-59BF4F59BEF1Q38504300-6AC8468D-794F-461A-B154-18DD1FBD90E8Q39290379-59392F64-68D0-4BA5-9052-8A707B6FB103Q40706082-8E786BF4-1255-4CA2-8031-AEADF8EE6128Q43500579-163A5847-0B3D-43EB-8331-B700E75E2A18Q45341253-11FF5A04-7318-4BA8-A955-918CFD09AFE6Q45876612-D692E483-66B5-4524-93C1-EEF8737BC531Q51778800-7A3C4051-339E-4F22-B0B5-1D1F433146FC
P2860
Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Fibrinogen-like protein 2 fibr ...... with severe viral hepatitis B
@ast
Fibrinogen-like protein 2 fibr ...... with severe viral hepatitis B
@en
Fibrinogen-like protein 2 fibr ...... with severe viral hepatitis B
@nl
type
label
Fibrinogen-like protein 2 fibr ...... with severe viral hepatitis B
@ast
Fibrinogen-like protein 2 fibr ...... with severe viral hepatitis B
@en
Fibrinogen-like protein 2 fibr ...... with severe viral hepatitis B
@nl
prefLabel
Fibrinogen-like protein 2 fibr ...... with severe viral hepatitis B
@ast
Fibrinogen-like protein 2 fibr ...... with severe viral hepatitis B
@en
Fibrinogen-like protein 2 fibr ...... with severe viral hepatitis B
@nl
P2093
P2860
P356
P1476
Fibrinogen-like protein 2 fibr ...... with severe viral hepatitis B
@en
P2093
Chuan-Long Zhu
De-Ying Tian
Wei-Ming Yan
Xiao-Ping Luo
Yong-Fen Zhu
P2860
P304
P356
10.3748/WJG.V11.I44.6936
P407
P577
2005-11-01T00:00:00Z